Literature DB >> 22986548

Equally potent? Does cellular reprogramming justify the abandonment of human embryonic stem cells?

Kristopher L Nazor1, Jeanne F Loring, Louise C Laurent.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22986548      PMCID： PMC3463969          DOI： 10.1038/embor.2012.134

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  16 in total

1.  Survival and death of epiblast cells during embryonic stem cell derivation revealed by long-term live-cell imaging with an Oct4 reporter system.

Authors:  Kazuo Yamagata; Jun Ueda; Eiji Mizutani; Mitinori Saitou; Teruhiko Wakayama
Journal:  Dev Biol       Date:  2010-07-24       Impact factor: 3.582

2.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

Authors:  Yoav Mayshar; Uri Ben-David; Neta Lavon; Juan-Carlos Biancotti; Benjamin Yakir; Amander T Clark; Kathrin Plath; William E Lowry; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

3.  Human embryonic stem cell lines derived from single blastomeres.

Authors:  Irina Klimanskaya; Young Chung; Sandy Becker; Shi-Jiang Lu; Robert Lanza
Journal:  Nature       Date:  2006-08-23       Impact factor: 49.962

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

6.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Adult mice generated from induced pluripotent stem cells.

Authors:  Michael J Boland; Jennifer L Hazen; Kristopher L Nazor; Alberto R Rodriguez; Wesley Gifford; Greg Martin; Sergey Kupriyanov; Kristin K Baldwin
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

9.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

Authors:  Kristopher L Nazor; Gulsah Altun; Candace Lynch; Ha Tran; Julie V Harness; Ileana Slavin; Ibon Garitaonandia; Franz-Josef Müller; Yu-Chieh Wang; Francesca S Boscolo; Eyitayo Fakunle; Biljana Dumevska; Sunray Lee; Hyun Sook Park; Tsaiwei Olee; Darryl D D'Lima; Ruslan Semechkin; Mana M Parast; Vasiliy Galat; Andrew L Laslett; Uli Schmidt; Hans S Keirstead; Jeanne F Loring; Louise C Laurent
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

10.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Authors:  Ryan Lister; Mattia Pelizzola; Yasuyuki S Kida; R David Hawkins; Joseph R Nery; Gary Hon; Jessica Antosiewicz-Bourget; Ronan O'Malley; Rosa Castanon; Sarit Klugman; Michael Downes; Ruth Yu; Ron Stewart; Bing Ren; James A Thomson; Ronald M Evans; Joseph R Ecker
Journal:  Nature       Date:  2011-02-02       Impact factor: 49.962
View more
  1 in total

1.  A caffeine fix for human nuclear transfer?

Authors:  Anthony C F Perry
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.